Enfermedad de Fabry Enfermedad de Fabry - Sociedad Argentina ...
Enfermedad de Fabry Enfermedad de Fabry - Sociedad Argentina ...
Enfermedad de Fabry Enfermedad de Fabry - Sociedad Argentina ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
manifestations. Arch Dermatol. 2004;140:1440-6.<br />
48. Lee K, Jin X, Zhang K, Copertino L, Andrews L, Baker-Malcolm J, Geagan<br />
L, Qiu H, Seiger K, Barngrover D, McPherson JM, Edmunds T. A biochemical<br />
and pharmacological comparison of enzyme replacement therapies for the<br />
glycolipid storage disor<strong>de</strong>r <strong>Fabry</strong> disease. Glycobiology. 2003;13:305-13.<br />
49. Lettieri, C, Inglese C, Preda P, Alfieri S, Gemignani F, Marbini A. Small fiber<br />
neuropathy in an 11-year-old boy with fabry disease. J Perip Ner Sys 2003; 8:<br />
53-54.<br />
50. Lockman LA, Hunninghake DB, Krivit W, Desnick RJ. Relief of pain of<br />
<strong>Fabry</strong>´s disease by diphenylhydantoin. Neurology 1973; 23: 871-875.<br />
51. MacDermot KD, Holmes A, Miners AH. An<strong>de</strong>rson-<strong>Fabry</strong> disease: clinical<br />
manifestations and impact of disease in a cohort of 60 obligate carrier<br />
females. J Med Genet 2001;38:769–75.<br />
52. MacDermot J, MacDermot KD. Neuropathic pain in An<strong>de</strong>rson-<strong>Fabry</strong><br />
disease: pathology and therapeutic options. Eur J Pharmacol 2001; 429: 121-<br />
125.<br />
53. MacDermot KD, Holmes A, Miners AH. An<strong>de</strong>rson-<strong>Fabry</strong> disease: clinical<br />
manifestations and impact of disease in a cohort of 98 hemizygous males. J<br />
Med Genet. 2001;38:750-60.<br />
54. Maier E, Osterrie<strong>de</strong>r S, Whybra C, Ries M, Gal A, Beck M, Roscher<br />
A, Muntau A. Disease manifestations and X inactivation in heterozygous<br />
females with <strong>Fabry</strong> disease. Acta Pædiatrica, 2006; Suppl 451: 30-38.<br />
55. Maisey DN, Cosh JA. Basilar artery aneurysm and An<strong>de</strong>rson-<strong>Fabry</strong><br />
disease. J Neurol Neurosurg Psychiatry 1980; 43: 85-7.<br />
56. Mastropasqua L, Nubile M, Lanzini M, Carpineto P, Toto L, Ciancaglini M.<br />
Corneal and conjunctival manifestations in <strong>Fabry</strong> disease: in vivo confocal<br />
microscopy study. Am J Ophthalmol. 2006 ;14:709-18.<br />
57. Meikle PJ, et al. Prevalence of lysosomal disor<strong>de</strong>rs. JAMA 1999; 28: 1249-<br />
1254.<br />
58. Melzack J. The short-form McGill Pain Questionnarie. Pain 1987; 30: 191-<br />
197.<br />
59. Mills K, Johnson A, Winchester B. Síntesis of novel internal standards<br />
for the quantitative <strong>de</strong>termination of plasma cerami<strong>de</strong> trihexosi<strong>de</strong> in <strong>Fabry</strong><br />
disease by tan<strong>de</strong>m mass spectrometry. FEBS Lett 2002 515: 171-176.<br />
60. Mills K, Vellodi A, Morris P, Cooper D, Morris M, Young E, Winchester B.<br />
Monitoring the clinical and biochemical response to enzyme replacement<br />
therapy in three children with <strong>Fabry</strong> disease. Eur J Pediatr 2004;163: 595-603.<br />
61. Mitsias P, Levine SR. Cerebrovascular complications of <strong>Fabry</strong>´s disease.<br />
Ann Neurol 1996; 40: 8-17.<br />
62. Moore DF, Altarescu G, Barker WC, Patronas NJ, Herscovitch P,<br />
Schiffmann R. White matter lesions in <strong>Fabry</strong> disease occur in ‘prior’<br />
selectively hypometabolic and hyperperfused brain regions. Brain Res Bull.<br />
2003; 62: 231-40.<br />
63. Moore DF, Schiffmann R, Ulug AM. Elevated CNS average diffusion<br />
constant in <strong>Fabry</strong> disease. Acta Paediatr Suppl. 2002;439: 67– 68.<br />
64. Moore DF, Scott LT, Gladwin MT, Altarescu G, Kaneski C, Suzuki K, Pease-<br />
Fye M, Ferri R, Brady RO, Herscovitch P, Schiffmann R. Regional cerebral<br />
hyperperfusion and nitric oxi<strong>de</strong> pathway dysregulation in <strong>Fabry</strong> disease:<br />
reversal by enzyme replacement therapy. Circulation. 2001 25;104:1506-12.<br />
65. Moore DF, Altarescu G, Ling GS, Jeffries N, Frei KP, Weibel T, Charria-Ortiz<br />
G, Ferri R, Arai AE, Brady RO, Schiffmann R. Elevated cerebral blood flow<br />
velocities in <strong>Fabry</strong> disease with reversal after enzyme replacement. Stroke.<br />
2002 ;33:525-31.<br />
66. Nguyen TT, Gin T, Nicholls K, Low M, Galanos J, Crawford A.<br />
Ophthalmological manifestations of <strong>Fabry</strong> disease: a survey of patients<br />
at the Royal Melbourne <strong>Fabry</strong> Disease Treatment Centre. Clin Experiment<br />
Ophthalmol. 2005;33:164-8.<br />
67. Ortiz A, Marron B. Treatment of <strong>Fabry</strong>’s disease: for whom, when, and<br />
how. Nefrologia. 2003;23(1):7-9.<br />
68. Pieroni M, Chimenti C, Ricci R, Sale P, Russo MA, Frustaci A. Early<br />
<strong>de</strong>tection of <strong>Fabry</strong> cardiomyopathy by tissue Doppler imaging. Circulation<br />
2003, 107:1978–1984.<br />
69. Pieroni M, Chimenti C, Russo A, Russo MA, Maseri A, Frustaci A. Tissue<br />
Doppler imaging in <strong>Fabry</strong> disease. Curr Opin Cardiol 2004, 19:452–457<br />
70. Politei JM, Pagano MA. Peripheral neuropathy in An<strong>de</strong>rson-<strong>Fabry</strong><br />
disease: its physiology, evaluation and treatment. Rev Neurol. 2004;38:979-83<br />
71. Politei JM, Capizzano AA. Magnetic resonance image findings in 5 young<br />
patients with <strong>Fabry</strong> disease. Neurologist. 2006;12:103-5.<br />
72. Pomar Blanco P, San Roman Carbajo J, Martin Villares C, Rodriguez Martin<br />
F, Paniagua J, Fernan<strong>de</strong>z Pello M, Tapia Risueno M. Otology manifestations of<br />
the An<strong>de</strong>rson-<strong>Fabry</strong> disease. Acta Otorrinolaringol Esp. 2006;57:115-7.<br />
73. Ramaswami U, Whybra C, Parini R, Pintos-Morell G, Mehta A, Sun<strong>de</strong>r-<br />
Plassmann G, Widmer U, Beck M; FOS European Investigators. Clinical<br />
manifestations of <strong>Fabry</strong> disease in children: data from the <strong>Fabry</strong> Outcome<br />
Survey. Acta Paediatr. 2006;95:86-92.<br />
74. Ries M, Mengel E, Kutschke G, Kim KS, Birklein F, Krummenauer, F, et al.<br />
Use of gabapentin to reduce chronic neuropathic pain in <strong>Fabry</strong> disease. J<br />
Inherit Metab Dis 2003; 26: 413-414.<br />
75. Ries M, Gupta S, Moore DF, Sach<strong>de</strong>v V, Quirk JM, Murray GJ, Rosing<br />
DR, Robinson C, Schaefer E, Gal A, Dambrosia JM, Garman SC, Brady RO,<br />
Schiffmann R. Pediatric <strong>Fabry</strong> disease. Pediatrics. 2005;115:e344-55.<br />
76. Sakuraba H, Murata-Ohsawa M, Kawashima I, Tajima Y, Kotani M,<br />
Ohshima T, Chiba Y, Takashiba M, Jigami Y, Fukushige T, Kanzaki T, Itoh K..<br />
Comparison of the effects of agalsidase alfa and agalsidase beta on cultured<br />
human <strong>Fabry</strong> fibroblasts and <strong>Fabry</strong> mice. J Hum Genet. 2006;51:180-8.<br />
77. Schiffmann R, Floeter MK, Dambrosia JM, Gupta S, Moore F, Sharabi Y,<br />
et al. Enzyme replacement therapy improves peripheral nerve and sweat<br />
function in <strong>Fabry</strong> disease. Muscle Nerve 2003;28:703-10.<br />
78. Schiffmann R, Kopp JB, Austin HA 3rd, Sabnis S, Moore DF, Weibel T, et al.<br />
Enzyme replacement therapy in <strong>Fabry</strong> disease: a randomized controlled trial.<br />
JAMA 2001; 285: 2743-2749.<br />
79. Scott LJC, Griffin JW, Luciano C, Barton NW, Banerjee T, Crawford JC, et<br />
al. Quantitative analysis of epi<strong>de</strong>rmal innervation in <strong>Fabry</strong> disease. Neurology<br />
1999; 52: 1249-1254.<br />
80. Sergi B, Conti G. Hearing loss in a family affected by <strong>Fabry</strong> disease. J<br />
Inherit Metab Dis. 2007 ;30(3):370-4.<br />
81. Shah JS, Hughes DA, Sach<strong>de</strong>v B, Tome M, Ward D, Lee P, Mehta AB,<br />
Elliott PM. Prevalence and Clinical Significance of Cardiac Arrhythmia in<br />
An<strong>de</strong>rson-<strong>Fabry</strong> Disease. Am J Cardiol 2005;96: 842– 846.<br />
82. Siamopoulos KC. <strong>Fabry</strong> disease: kidney involvement and enzyme<br />
replacement therapy. Kidney Int. 2004;65:744-53.<br />
83. Thurberg BL, Randolph Byers H, Granter SR, Phelps RG, Gordon RE,<br />
O’Callaghan M. Monitoring the 3-year efficacy of enzyme replacement<br />
therapy in fabry disease by repeated skin biopsies. J Invest Dermatol.<br />
2004;122:900-8<br />
84. Utsumi K, Yamamoto N, Kase R, et al. High inci<strong>de</strong>nce of thrombosis in<br />
<strong>Fabry</strong>’s disease. Intern Med. 1997; 36: 327-9.<br />
85. Uyama E, Ueno N, Uchino M, Narahara T, Owada M, Taketomi T, Ando M.<br />
Headache associated with aseptic meningeal reaction as clinical onset of<br />
<strong>Fabry</strong>’s disease. Headache. 1995;35:498-501.<br />
86. Váyanse H, Chaba T, Clarke L, Taylor G. Pseudo-lysosomal storage disease<br />
caused by EMLA cream. J. Inherit. metab. Dis. 2004;27:507-511.<br />
87. Vibert D, Blaser B, Ozdoba C, Häusler R. <strong>Fabry</strong>\’s disease: otoneurologic<br />
findings in twelve members of one family Ann Otol Rhinol Laryngol. 2006<br />
;115(6):412-8.<br />
88. Warnock DG, West ML. Diagnosis and management of kidney involvement<br />
in <strong>Fabry</strong> disease. Adv Chronic Kidney Dis. 2006;13:138-47.<br />
89. Wei<strong>de</strong>mann F, Breunig F, Beer M, Sandste<strong>de</strong> J, Turschner O, Voelker W,<br />
Ertl G, Knoll A, Wanner C, Strotmann JM. Improvement of Cardiac Function<br />
During Enzyme Replacement Therapy in Patients With <strong>Fabry</strong> Disease. A<br />
Prospective Strain Rate Imaging Study. Circulation. 2003;108:1299-1301<br />
90. Whybra C, Kampmann C, Willers I, Davies J, Winchester B, Kriegsmann<br />
J, Bruhl K, Gal A, Bunge S, Beck M. An<strong>de</strong>rson-<strong>Fabry</strong> disease: clinical<br />
manifestations of disease in female heterozygotes. J Inherit Metab Dis<br />
2001;24:715–24.<br />
91. Young E, Mills K, Morris P, Vellodi A, Lee P, Wal<strong>de</strong>k S, Winchester B. Is<br />
globotriaosylcerami<strong>de</strong> a useful biomarker in <strong>Fabry</strong> disease Acta Pædiatrica<br />
2005; 94(Suppl 447): 51–54.<br />
14